The lack of overall survival difference based on IL8 levels in our stage-stratified CRC patients is in contrast to a prior report that showed higher IL8 level led to decrease overall survival in non-stratified stage I–IV colon cancer patients [35, 36]. The gene discussed is CXCL8; the disease is colorectal carcinoma.